Molecular Endocrinology, Vol 10, 575-584, Copyright © 1996 by Endocrine Society

ARTICLES

Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR

WR Zhang, PM Li, MA Oswald and BJ Goldstein
Dorrance H. Hamilton Research Laboratories, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Protein-tyrosine phosphatases (PTPases) regulate insulin signaling by catalyzing the tyrosine dephosphorylation of the insulin receptor and its substrate proteins. Previous studies have implicated a PTPase localized to a cell membrane fraction in the regulation of the insulin receptor in situ. LAR (leukoyte antigen related) is a transmembrane PTPase in insulin-sensitive tissues with in vitro catalytic specificity for the insulin receptor kinase domain. When transfected into Chinese hamster ovary cells overexpressing the human insulin receptor (CHO- hlR), the LAR protein was processed as expected into an 85-kDa subunit containing the transmembrane and cytoplasmic domains. LAR was increased an average of 6-fold in clonal lines of stably transfected cells, and cell fractionation confirmed its localization in the cell membrane. After stimulation with 100 nM insulin, tyrosine phosphorylation of the insulin receptor was decreased by 31% at 1 min (P < 0.01) and by 42% at 10 min (P < 0.01), and that of IRS-1 was decreased by 34% (P < 0.01) at 1 min and by 56% (P < 0.01) at 10 min in the LAR-overexpressing cells compared with empty vector transfectants. LAR overexpression also blocked insulin-stimulated receptor kinase activation as well as thymidine incorporation into DNA. Quantitatively similar results were obtained in populations of CHO-hlR cells transfected transiently by electroporation. In contrast, overexpression of recombinant LAR cytoplasmic domain, detected as a 72-kDa protein in the cell cytosol, did not significantly affect the insulin-stimulated tyrosine phosphorylation of the insulin receptor or IRS-1 (99% and 93% of control at 10 min, respectively). These studies provide the first evidence that increased expression of LAR has negative regulatory effects at a proximal site in the insulin-signaling pathway. Since this effect occurs only when LAR is eutopically expressed at the cell membrane, these data further suggest that LAR requires a transmembrane localization to directly interact with the insulin receptor in situ.

This article has been cited by other articles:

				W.-K. Kim, H. Jung, D.-H. Kim, E.-Y. Kim, J.-W. Chung, Y.-S. Cho, S.-G. Park, B.-C. Park, Y. Ko, K.-H. Bae, et al. Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes J. Cell Sci., November 15, 2009; 122(22): 4160 - 4167. [Abstract] [Full Text] [PDF]

				S. Aga-Mizrachi, T. Brutman-Barazani, A. I. Jacob, A. Bak, A. Elson, and S. R. Sampson Cytosolic Protein Tyrosine Phosphatase-{epsilon} Is a Negative Regulator of Insulin Signaling in Skeletal Muscle Endocrinology, February 1, 2008; 149(2): 605 - 614. [Abstract] [Full Text] [PDF]

				A. W Stoker Protein tyrosine phosphatases and signalling J. Endocrinol., April 1, 2005; 185(1): 19 - 33. [Abstract] [Full Text] [PDF]

				S. Galic, C. Hauser, B. B. Kahn, F. G. Haj, B. G. Neel, N. K. Tonks, and T. Tiganis Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP Mol. Cell. Biol., January 15, 2005; 25(2): 819 - 829. [Abstract] [Full Text] [PDF]

				J. M. Zabolotny, F. G. Haj, Y.-B. Kim, H.-J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, and B. B. Kahn Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action J. Biol. Chem., June 4, 2004; 279(23): 24844 - 24851. [Abstract] [Full Text] [PDF]

				E. Asante-Appiah and B. P. Kennedy Protein tyrosine phosphatases: the quest for negative regulators of insulin action Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E663 - E670. [Abstract] [Full Text] [PDF]

				B. J. Goldstein Protein-Tyrosine Phosphatases: Emerging Targets for Therapeutic Intervention in Type 2 Diabetes and Related States of Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2474 - 2480. [Full Text] [PDF]

				X. Wu, J. Hoffstedt, W. Deeb, R. Singh, N. Sedkova, A. Zilbering, L. Zhu, P. K. Park, P. Arner, and B. J. Goldstein Depot-Specific Variation in Protein-Tyrosine Phosphatase Activities in Human Omental and Subcutaneous Adipose Tissue: A Potential Contribution to Differential Insulin Sensitivity J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5973 - 5980. [Abstract] [Full Text] [PDF]

				J. M. Zabolotny, Y.-B. Kim, O. D. Peroni, J. K. Kim, M. A. Pani, O. Boss, L. D. Klaman, S. Kamatkar, G. I. Shulman, B. B. Kahn, et al. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance PNAS, April 12, 2001; (2001) 71050398. [Abstract] [Full Text]

				K. Tsujikawa, N. Kawakami, Y. Uchino, T. Ichijo, T. Furukawa, H. Saito, and H. Yamamoto Distinct Functions of the Two Protein Tyrosine Phosphatase Domains of LAR (Leukocyte Common Antigen-Related) on Tyrosine Dephosphorylation of Insulin Receptor Mol. Endocrinol., February 1, 2001; 15(2): 271 - 280. [Abstract] [Full Text]

				S. Tang, H. Le-Tien, B. J. Goldstein, P. Shin, R. Lai, and I. G. Fantus Decreased In Situ Insulin Receptor Dephosphorylation in Hyperglycemia-Induced Insulin Resistance in Rat Adipocytes Diabetes, January 1, 2001; 50(1): 83 - 90. [Abstract] [Full Text]

				M. R. Calera, G. Vallega, and P. F. Pilch Dynamics of Protein-tyrosine Phosphatases in Rat Adipocytes J. Biol. Chem., February 25, 2000; 275(9): 6308 - 6312. [Abstract] [Full Text] [PDF]

				B. T. Solow, S. Harada, B. J. Goldstein, J. A. Smith, M. F. White, and L. Jarett Differential Modulation of the Tyrosine Phosphorylation State of the Insulin Receptor by IRS (Insulin Receptor Subunit) Proteins Mol. Endocrinol., October 1, 1999; 13(10): 1784 - 1798. [Abstract] [Full Text]

				C. H. Arnott, E. M. Sale, J. Miller, and G. J. Sale Use of an Antisense Strategy to Dissect the Signaling Role of Protein-tyrosine Phosphatase alpha J. Biol. Chem., September 10, 1999; 274(37): 26105 - 26112. [Abstract] [Full Text] [PDF]

				F. Ahmad and B. J. Goldstein Functional Association between the Insulin Receptor and the Transmembrane Protein-tyrosine Phosphatase LAR in Intact Cells J. Biol. Chem., January 3, 1997; 272(1): 448 - 457. [Abstract] [Full Text] [PDF]

				N. Begum and L. Ragolia cAMP Counter-regulates Insulin-mediated Protein Phosphatase-2A Inactivation in Rat Skeletal Muscle Cells J. Biol. Chem., December 6, 1996; 271(49): 31166 - 31171. [Abstract] [Full Text] [PDF]

				S. Qiao, T. Iwashita, T. Furukawa, M. Yamamoto, G. Sobue, and M. Takahashi Differential Effects of Leukocyte Common Antigen-related Protein on Biochemical and Biological Activities of RET-MEN2A and RET-MEN2B Mutant Proteins J. Biol. Chem., March 16, 2001; 276(12): 9460 - 9467. [Abstract] [Full Text] [PDF]

				J. M. Zabolotny, Y.-B. Kim, O. D. Peroni, J. K. Kim, M. A. Pani, O. Boss, L. D. Klaman, S. Kamatkar, G. I. Shulman, B. B. Kahn, et al. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance PNAS, April 24, 2001; 98(9): 5187 - 5192. [Abstract] [Full Text] [PDF]